D2M INNOVATION LIMITED
Company number 07405791 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: D2M Innovation Limited
1. Financial Health Score: C+
Explanation: The patient is in stable but guarded condition — recovering from a significant financial illness in 2022 but not yet returned to full strength. The business shows encouraging vital signs with improving profitability and a strengthening cash position, but remains heavily reliant on creditor financing, leaving it vulnerable to external shocks. Think of this as a patient who has successfully come off the critical list but still requires careful monitoring and lifestyle changes before being discharged.
2. Key Vital Signs
Heart Rate — Liquidity Health
| Metric | 2025 | 2024 | Assessment |
|---|---|---|---|
| Current Ratio | 1.19x | 1.01x | ⚠️ Adequate but tight |
| Cash Ratio | 0.69x | 0.60x | ⚠️ Moderate improvement |
| Net Current Assets | £24,608 | £1,047 | ✅ Significant improvement |
Interpretation: The current ratio has improved from a dangerously thin 1.01x to 1.19x — meaning for every £1 of short-term debts, the company has £1.19 of short-term assets. This is like having just enough oxygen while exercising — functional but no buffer for unexpected exertion. The jump in net current assets from £1,047 to £24,608 is the most encouraging sign here, moving from near-zero working capital to a meaningful cushion.
Blood Pressure — Solvency & Leverage
| Metric | 2025 | 2024 | Assessment |
|---|---|---|---|
| Net Assets | £32,026 | £11,475 | ✅ Strong recovery |
| Debt-to-Equity Ratio | 4.05x | 12.33x | ⚠️ Improving but still elevated |
| Equity as % of Total Assets | 19.6% | 7.5% | ⚠️ Improving from weak base |
Interpretation: The debt-to-equity ratio has improved dramatically from 12.33x to 4.05x — this is like a patient whose blood pressure has come down from hypertensive crisis to "stage 1 hypertension." Better, but still requiring treatment. The company remains heavily dependent on creditor financing, with nearly 80% of assets funded by liabilities rather than equity.
Body Temperature — Profitability Trend
| Metric | 2025 | 2024 | Assessment |
|---|---|---|---|
| P&L Reserve Movement | +£20,551 | — | ✅ Healthy profit generated |
| Net Asset Growth | +180% | — | ✅ Strong recovery |
| Retained Earnings | £31,906 | £11,355 | ✅ Positive trajectory |
Interpretation: The P&L reserve grew by approximately £20,551, indicating a profitable year. This is the financial equivalent of a fever breaking — the business is generating positive returns again after the distress of 2022.
Respiratory Function — Cash Flow Health
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash at Bank | £89,632 | £84,944 | £102,215 | £15,009 |
| Cash as % of Current Liabilities | 69% | 60% | 65% | 11% |
Interpretation: Cash levels remain healthy at £89,632, covering 69% of current liabilities. The 2022 cash position of just £15,009 was the financial equivalent of shallow, laboured breathing — the company has since restored healthy respiratory function. However, cash has declined from the 2023 peak of £102,215, suggesting some cash consumption.
3. Diagnosis
Primary Condition: Post-Distress Recovery with Residual Vulnerability
The financial data reveals a business that suffered a severe financial episode in FY2022 when net assets fell to negative £17,742 and cash dwindled to just £15,009. This was the equivalent of a cardiac event — the business was technically insolvent on a net assets basis.
Timeline of the Patient's Condition:
| Year | Net Assets | Cash | Condition |
|---|---|---|---|
| 2020 | £115,448 | £49,001 | 🟢 Healthy |
| 2021 | £31,231 | £78,249 | 🟡 Moderate — significant equity decline but cash stable |
| 2022 | (£17,742) | £15,009 | 🔴 Critical — insolvent, cash depleted |
| 2023 | £21,632 | £102,215 | 🟡 Recovering — equity restored, cash rebuilt |
| 2024 | £11,475 | £84,944 | 🟡 Setback — equity dipped, cash slightly down |
| 2025 | £32,026 | £89,632 | 🟢 Improving — best position since 2021 |
Symptom Analysis:
1. Structural Weakness — Thin Equity Cushion With only £32,026 in net assets against £129,912 in current liabilities, the equity buffer remains dangerously thin. A £32,000 bad debt or unexpected liability could wipe out the entire net worth. This is the financial equivalent of operating with minimal immune reserves — any infection could become serious.
2. Heavy Creditor Dependence The business operates on what is essentially a "creditor-financed" model. Current liabilities of £129,912 fund the majority of operations. While common in design consultancies, this creates a dependency on supplier goodwill and timely cash collection. If key creditors tighten terms, the working position could deteriorate rapidly.
3. Volatile Earnings Pattern The dramatic swings in net assets (from £115,448 to negative £17,742 and back) suggest a business model with significant revenue or project concentration risk. This volatility is concerning — it suggests the company may be project-dependent with lumpy income streams.
4. Positive Signs — Healing in Progress - Net current assets improved from £1,047 to £24,608 - Cash remains robust at £89,632 - Profitability has returned (P&L reserve growth of £20,551) - Debtors increased from £50,704 to £59,027 (may indicate growing revenue) - Total liabilities reduced by approximately £11,600
5. Minor Concern — Deferred Tax Liability A deferred tax liability of £1,270 has appeared in 2025 (nil in 2024). This is small but worth monitoring — it suggests timing differences in tax treatment, possibly related to capital allowances or accrual adjustments.
4. Recommendations
Immediate Treatment (0-6 months)
1. Build the Equity Cushion The priority should be retaining profits to rebuild equity rather than distributing to shareholders. With only £32,026 in net assets, the target should be to reach at least £50,000-£75,000 before considering any dividend payments. Think of this as building up the patient's strength before resuming normal activities.
2. Debtor Management Protocol Debtors increased by 16.5% (£50,704 to £59,027) — ensure this is not indicative of slowing collections. Implement rigorous credit control: - Review aged debtor reports monthly - Set maximum credit terms of 30 days - Chase overdue invoices within 7 days of due date - Consider invoice financing if working capital pressure increases
3. Creditor Terms Review With £129,912 in current liabilities, negotiate extended payment terms where possible. Even moving from 30-day to 45-day terms with key suppliers would provide meaningful breathing room.
Medium-Term Rehabilitation (6-18 months)
4. Revenue Diversification The historical volatility strongly suggests revenue concentration risk. The business should: - Reduce dependency on any single client or project type - Develop recurring revenue streams (retainer arrangements, licensing) - Build a pipeline that smooths income across quarters
5. Working Capital Targeting Aim to increase the current ratio to at least 1.5x and maintain net current assets above £40,000. This provides a healthy buffer against the type of shock experienced in 2022.
6. Cash Reserve Policy Maintain a minimum cash balance of £50,000 (approximately 5-6 months of operating costs based on the business size). This acts as a financial immune system against unexpected challenges.
Long-Term Wellness (18+ months)
7. Financial Health Monitoring Implement quarterly financial health checks tracking: - Current ratio (target: >1.5x) - Debtor days (target: <35 days) - Net assets trend (target: consistent growth) - Cash as percentage of current liabilities (target: >75%)
8. Consider Capital Restructuring The share capital of just £120 is nominal. If the business continues to recover, consider a formal capitalisation of retained profits through a bonus issue to strengthen the balance sheet's appearance to third parties.
9. Risk Management Given the business operates in "specialised design activities" (SIC 74100) — a sector that can be cyclical and project-dependent — build scenario plans for: - Loss of largest client - Economic downturn reducing design spend - Key personnel risk (family-run business with Staunton family dependence)
Summary Risk Assessment
| Risk Category | Level | Notes |
|---|---|---|
| Insolvency Risk | 🟡 Medium | Positive net assets but thin equity cushion |
| Liquidity Risk | 🟡 Medium | Improving but current ratio still below 1.5x |
| Cash Flow Risk | 🟢 Low-Medium | Healthy cash balance maintained |
| Profitability Risk | 🟢 Low | Profitable and improving |
| Volatility Risk | 🟠 Medium-High | History of significant financial swings |